No profile data available.
Scienture Holdings, Inc. (SCNX) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Commack, United States, with about 4 full-time employees.
It reported revenue of $431,609 for fiscal year 2025, up 215.9% from fiscal year 2024, and net income of -$41.51 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $56,325, up 449.1% from a year before. Its market capitalization was $6.18 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.
Scienture reported $431,609 in revenue for fiscal year 2025, up 215.9% from $136,643 in fiscal year 2024. In Q1 2026 revenue was $56,325.
$6.18 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include OSR Holdings, Inc. (OSRH), VitaSpring Biomedical Co. Ltd. (VSBC), America Great Health (AAGH), Revelation Biosciences, Inc. (REVB).